Jonathan Beaudoin1, Jacob P Dal-Bianco1, Elena Aikawa1, Joyce Bischoff1, J Luis Guerrero1, Suzanne Sullivan1, Philipp Emanuel Bartko1, Mark D Handschumacher1, Dae-Hee Kim1, Jill Wylie-Sears1, Jacob Aaron1, Robert A Levine2. 1. From the Cardiac Ultrasound Laboratory, Massachusetts General Hospital (J.B., J.P.D.-B., J.L.G., S.S., P.E.B., M.D.H., D.-H.K., R.A.L.), Vascular Biology Program and Department of Surgery, Children's Hospital (J.B., J.W.-S.), Vascular Biology Program, Center for Interdisciplinary Cardiovascular Sciences, Brigham and Women's Hospital (E.A., J.A.), Harvard Medical School, Boston, and Division of Cardiology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea (D.-H.K.). 2. From the Cardiac Ultrasound Laboratory, Massachusetts General Hospital (J.B., J.P.D.-B., J.L.G., S.S., P.E.B., M.D.H., D.-H.K., R.A.L.), Vascular Biology Program and Department of Surgery, Children's Hospital (J.B., J.W.-S.), Vascular Biology Program, Center for Interdisciplinary Cardiovascular Sciences, Brigham and Women's Hospital (E.A., J.A.), Harvard Medical School, Boston, and Division of Cardiology, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, South Korea (D.-H.K.). rlevine@partners.org.
Abstract
BACKGROUND: Ischemic mitral regurgitation (MR) is classically ascribed to functional restriction of normal leaflets, but recent studies have suggested post-myocardial infarction (MI) mitral valve (MV) leaflet fibrosis and thickening, challenging valve normality. Progression of leaflet thickness post-MI has not been studied. We hypothesized that excessive MV remodeling post-MI contributes to MR. Our objectives are to characterize MV changes after MI and relate them to MR. METHODS AND RESULTS: Three groups of 40 patients with serial echocardiograms over a mean of 23.4 months were identified from an echocardiography database: patients first studied early (6±12 days) and late (12±7 years) after an inferior MI and normal controls. MV thickness was correlated with MR. We studied the mechanisms for MV changes in a sheep model (6 apical MI versus 6 controls) followed for 8 weeks, with MV cellular and histopathologic analyses. Early post-MI, leaflet thickness was found to be similar to controls (2.6±0.5 vs 2.5±0.4 mm; P=0.23) but significantly increased over time (2.5±0.4 to 2.9±0.4 mm; P<0.01). In this group, patients tolerating maximal doses of renin-angiotensin blocking agents had less thickening (25% of patients; P<0.01). The late-MI group had increased thickness (3.2±0.5 vs 2.5±0.4 mm; P<0.01) without progression. At follow-up, 48% of post-MI patients had more than mild MR. Increased thickness was independently associated with MR. Experimentally, 8 weeks post-MI, MVs were 2-fold thicker than controls, with increased collagen, profibrotic transforming growth factor-β, and endothelial-to-mesenchymal transformation, confirmed by flow cytometry. CONCLUSIONS: MV thickness increases post-MI and correlates with MR, suggesting an organic component to ischemic MR. MV fibrotic remodeling can indicate directions for future therapy.
BACKGROUND:Ischemic mitral regurgitation (MR) is classically ascribed to functional restriction of normal leaflets, but recent studies have suggested post-myocardial infarction (MI) mitral valve (MV) leaflet fibrosis and thickening, challenging valve normality. Progression of leaflet thickness post-MI has not been studied. We hypothesized that excessive MV remodeling post-MI contributes to MR. Our objectives are to characterize MV changes after MI and relate them to MR. METHODS AND RESULTS: Three groups of 40 patients with serial echocardiograms over a mean of 23.4 months were identified from an echocardiography database: patients first studied early (6±12 days) and late (12±7 years) after an inferior MI and normal controls. MV thickness was correlated with MR. We studied the mechanisms for MV changes in a sheep model (6 apical MI versus 6 controls) followed for 8 weeks, with MV cellular and histopathologic analyses. Early post-MI, leaflet thickness was found to be similar to controls (2.6±0.5 vs 2.5±0.4 mm; P=0.23) but significantly increased over time (2.5±0.4 to 2.9±0.4 mm; P<0.01). In this group, patients tolerating maximal doses of renin-angiotensin blocking agents had less thickening (25% of patients; P<0.01). The late-MI group had increased thickness (3.2±0.5 vs 2.5±0.4 mm; P<0.01) without progression. At follow-up, 48% of post-MI patients had more than mild MR. Increased thickness was independently associated with MR. Experimentally, 8 weeks post-MI, MVs were 2-fold thicker than controls, with increased collagen, profibrotic transforming growth factor-β, and endothelial-to-mesenchymal transformation, confirmed by flow cytometry. CONCLUSIONS: MV thickness increases post-MI and correlates with MR, suggesting an organic component to ischemic MR. MV fibrotic remodeling can indicate directions for future therapy.
Authors: Michael H Picard; Ravin Davidoff; Lynn A Sleeper; Lisa A Mendes; Christopher R Thompson; Vladimir Dzavik; Richard Steingart; Ken Gin; Harvey D White; Judith S Hochman Journal: Circulation Date: 2003-01-21 Impact factor: 29.690
Authors: Ronen Beeri; Chaim Yosefy; J Luis Guerrero; Francesca Nesta; Suzan Abedat; Miguel Chaput; Federica del Monte; Mark D Handschumacher; Robert Stroud; Suzanne Sullivan; Thea Pugatsch; Dan Gilon; Gus J Vlahakes; Francis G Spinale; Roger J Hajjar; Robert A Levine Journal: J Am Coll Cardiol Date: 2008-01-29 Impact factor: 24.094
Authors: M Komeda; J R Glasson; A F Bolger; G T Daughters; A MacIsaac; S N Oesterle; N B Ingels; D C Miller Journal: Circulation Date: 1997-11-04 Impact factor: 29.690
Authors: K Jane Grande-Allen; Allen G Borowski; Richard W Troughton; Penny L Houghtaling; Nicholas R Dipaola; Christine S Moravec; Ivan Vesely; Brian P Griffin Journal: J Am Coll Cardiol Date: 2005-01-04 Impact factor: 24.094
Authors: William D Meador; Mrudang Mathur; Gabriella P Sugerman; Tomasz Jazwiec; Marcin Malinowski; Matthew R Bersi; Tomasz A Timek; Manuel K Rausch Journal: Acta Biomater Date: 2019-11-22 Impact factor: 8.947
Authors: Dae-Hee Kim; Jacob P Dal-Bianco; Elena Aikawa; Joyce Bischoff; Robert A Levine Journal: Circ Cardiovasc Imaging Date: 2018-04 Impact factor: 7.792
Authors: Bruno V Rego; Amir H Khalighi; Joseph H Gorman; Robert C Gorman; Michael S Sacks Journal: Ann Biomed Eng Date: 2022-08-27 Impact factor: 4.219
Authors: Amélie Paquin; Ons Marsit; Valérie Deschênes; Dounia Rouabhia; Sandra Hadjadj; Marine Clisson; Charlotte Robitaille; Elena Aikawa; Robert A Levine; Philippe Pibarot; Marie-Annick Clavel; Jonathan Beaudoin Journal: Open Heart Date: 2022-06
Authors: Yue Zhang; Vicky Y Wang; Ashley E Morgan; Jiwon Kim; Mark D Handschumacher; Chaya S Moskowitz; Robert A Levine; Liang Ge; Julius M Guccione; Jonathan W Weinsaft; Mark B Ratcliffe Journal: PLoS One Date: 2019-10-10 Impact factor: 3.240
Authors: Daniel P Howsmon; Bruno V Rego; Estibaliz Castillero; Salma Ayoub; Amir H Khalighi; Robert C Gorman; Joseph H Gorman; Giovanni Ferrari; Michael S Sacks Journal: J R Soc Interface Date: 2020-05-06 Impact factor: 4.118